Address |
177-181, avenue Pierre Brossolette Montrouge Ile-de-France 92120 France |
Employees | - |
Website | http://www.dbv-technologies.com |
Updated | 07/08/2019 |
DBV Technologies SA is a clinical-stage biopharmaceutical company, which deals with conducting of research and development of epicutaneous immunotherapy products. It focuses on developing a novel technology platform called Viaskin, which is an electrostatic patch that offers a convenient, self-administered, non-invasive immunotherapy to patients. The company has designed two products candidates: Viaskin Peanut and Viaskin Milk. |